Live News Categoriesmarket

688302 (688302) News

Follow 688302 (688302) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 688302 Asset market Sector Markets 90 days 1 Updated Nov 04, 2026, 10:24 PM UTC Open live news feed

M Evommune Licenses Hinova Autoimmune Drug in Deal Worth Up to $1.1 Billion Evommune said it licensed rights to an experimental autoimmune disease treatment from China's Hinova Pharmaceuticals, with up to about $1.1 billion in milestone payments. MNA | Nov 04, 2026, 10:24 PM UTC